ADVERTISEMENT

Transitions Magazine

Transitions is published bi-monthly for members of the APhA New Practitioner Network. The online newsletter contains information focused on life inside and outside pharmacy practice, providing guidance on various areas of professional, personal, and practice development. Each issue includes in-depth articles on such topics as personal financial management, innovative practice sites, career profiles, career development tools, residency and postgraduate programs, and more.

CDC seeks to expand University of Michigan’s pharmacist hypertension... CDC seeks to expand University of Michigan’s pharmacist hypertension...

CDC seeks to expand University of Michigan’s pharmacist hypertension...

0 5894

According to CDC's recent assessment of the University of Michigan’s Hypertension Pharmacists’ Program (HPP), 66% of patients who consulted with an HPP pharmacist brought their disease under control within 3 months compared with 42% of patients who did not meet with a pharmacist. At 6 months, 69% had their BP under control compared with 56% of nonparticipants.

Low-dose aspirin during pregnancy appears to have no effect on child’s... Low-dose aspirin during pregnancy appears to have no effect on child’s...

Low-dose aspirin during pregnancy appears to have no effect on child’s...

0 6262
Low-dose aspirin during pregnancy is safe, according to a new study published in The American College of Obstetricians and Gynecologists’ Obstetrics and Gynecology. Researchers found that the Bayley Scales of Infant and Toddler Development (Bayley-III) cognitive composite scores indicated no difference when pregnant parents took low-dose...
BP improves with patients taking GLP-1, says study BP improves with patients taking GLP-1, says study

BP improves with patients taking GLP-1, says study

Results from a new study published in the American Heart Association’s Hypertension showed that the GLP-1, tirzepatide, reduced 24-hour...
0 6185
Why are cases of syphilis soaring? Why are cases of syphilis soaring?

Why are cases of syphilis soaring?

CDC stated that the United States is seeing the highest incidence of syphilis since 1950. In its new report, the agency maps out an astonishing...
0 4005
Is naloxone at the counter getting less costly? Is naloxone at the counter getting less costly?

Is naloxone at the counter getting less costly?

Patients paid less money out of pocket for naloxone from 2018 through 2022, according to a new analysis published in JAMA. The research, which was...
0 6357
Fresh data finds gabapentin use trends upward in U.S. Fresh data finds gabapentin use trends upward in U.S.

Fresh data finds gabapentin use trends upward in U.S.

Incorporating an additional 6 years of data, researchers updated a previously published analysis of gabapentinoid use among Americans.

0 4107

FDA adds boxed warning to denosumab specific for patients with advanced CKD

FDA added a boxed warning to the osteoporosis drug denosumab (Prolia). The agency’s review of the drug indicated risks that warrant new prescribing information. For patients with chronic kidney disease (CKD)—especially those on dialysis or those with a concomitant diagnosis of mineral and bone disorder—FDA said they could develop severe hypocalcemia, or very low levels of...

CDC releases detailed adult immunization schedule for 2024, with revisions

CDC’s adult immunization schedule for 2024, which was published in the Annals of Internal Medicine on January 12, 2024, includes updates for several vaccines, including those for respiratory syncytial virus (RSV), meningitis, mpox, and COVID-19. The immunization schedule is based on the recommendations of CDC’s ACIP.

123468910Last
Advertisement
Advertisement
Advertisement
Advertisement

ADVERTISEMENT